Phase II Study of Olaparib in Subjects With Malignant Mesothelioma
Phase of Trial: Phase II
Latest Information Update: 17 Sep 2019
Price : $35 *
At a glance
- Drugs Olaparib (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- 11 Jul 2018 Planned initiation date (estimated date for recruitment of the first subject) changed from 29 Jun 2018 to 16 Jul 2018.
- 03 Jul 2018 Status changed from not yet recruiting to recruiting.
- 23 Jun 2018 Planned initiation date changed from 4 Jun 2018 to 26 Jun 2018.